In this issue of the Journal, Tarantino et al .[1][1] describe their experience with the use of romiplostim to treat children with persistent immune thrombocytopenia (ITP). The results of this… Click to show full abstract
In this issue of the Journal, Tarantino et al .[1][1] describe their experience with the use of romiplostim to treat children with persistent immune thrombocytopenia (ITP). The results of this study also have implications for management of children who present with ITP.[1][1] Eighty to 90% of
               
Click one of the above tabs to view related content.